Author:
Tu Yifeng,Han Junjun,Dong Quanjin,Chai Rui,Li Na,Lu Qiliang,Xiao Zunqiang,Guo Yang,Wan Ziang,Xu Qiuran
Funder
Natural Science Foundation of Zhejiang Province
the Funding Project Zhejiang People's Hospital
the Funding Project of Health and Family Planning Commission of Zhejiang Province
the Funding Project Administration of Traditional Chinese Medicine of Zhejiang Province
he Funding Project of CSCO, Chinese Society of Clinical Oncology
Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference42 articles.
1. Colorectal cancer;H;Nature,2015
2. Colorectal cancer statistics, 2017;RL;CA Cancer J Clin,2017
3. Immunotherapy in colorectal cancer: rationale, challenges, and potential;K;Nat Rev Gastroenterol Hepatol,2019
4. Current status and future directions of the immune checkpoint inhibitors ipilimumab, pembrolizumab, and nivolumab in oncology;MS;Ann Pharmacother,2015
5. Pembrolizumab for the treatment of non-small-cell lung cancer;EB;N Engl J Med,2015
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献